Reference : Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridin...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
Engineering, computing & technology : Computer science
http://hdl.handle.net/2268/2325
Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: A new step towards the design of high-affinity 5-HT1A ligands
English
Dilly, Sébastien mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Pharmacologie >]
Graulich, Amaury [ > > ]
Liégeois, Jean-François mailto [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >]
Jan-2010
Bioorganic & Medicinal Chemistry Letters
Elsevier Science
20
2
1118-1123
Yes (verified by ORBi)
International
0960-894X
1464-3405
Oxford
United Kingdom
[en] 5-HT1A receptors ; Arylpiperazine ; 1,2,3,6-Tetrahydropyridine ; Conformational analysis ; CH–Pi interaction
[en] The main feature of many drugs having a 5-HT1A affinity is the presence of an arylpiperazine moiety. Indeed, the protonated nitrogen and the aromatic ring of the arylpiperazine compounds are considered crucial for the interaction with the receptor. However, the replacement of the piperazine moiety by a 1,2,3,6-tetrahydropyridine ring in 4-arylpiperazine-ethyl carboxamide derivatives was recently shown to be highly favourable for 5-HT1A affinity. In order to better understand the favourable effect of this chemical modification, we performed a conformational analysis of these compounds mainly based on the position of the phenyl ring relative to the piperazine and tetrahydropyridine moiety. In the piperazine compounds, the phenyl ring preferentially adopts a perpendicular orientation, whereas an almost planar orientation seems to be the most favourable conformation for the tetrahydropyridine compounds. Therefore, this conformational difference appears as a key for a better interaction with the receptor binding site. This result will serve for the designing high-affinity 5-HT1A ligands.
Laboratory of Medicinal Chemistry, Drug Research Center
Fonds National de la Recherche Scientifique (F.R.S-FNRS), fonds spéciaux pour la recherche ULg, Fondation Léon Frédéricq
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/2325
10.1016/j.bmcl.2009.12.027

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
DillyS BMCL 2010.pdfPublisher postprint919.46 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.